THE BRITISH ASSOCIATION OF DERMATOLOGISTS
Patient Information and Leaflets
What is a Dermatologist
Become a Case Study
Skin Cancer
Information about Dermatology Services
Patient Support Groups
Information about your health rights

Search Site
Enter Text

Member Login
If you are a member, please log in below
Username:
Password:
     
 |  Forget Password
 
>> Pyoderma gangrenosum

You can download this leaflet by clicking here

Patient Information Leaflet

Pyoderma gangrenosum 

What are the aims of this leaflet?

This leaflet has been written to help you understand more about pyoderma gangrenosum. It tells you what it is, what conditions may be associated with it, what can be done about it, and where you can find out more about it.

What is pyoderma gangrenosum?

Pyoderma gangrenosum is a rare treatable cause of skin ulcers. It is not related to gangrene. Pyoderma gangrenosum is not ‘catching’ and cannot be transferred from or to another person by touching or in any other way.

What causes pyoderma gangrenosum?

For about half of the people with pyoderma gangrenosum there are no known reasons for it. It may start after minor skin damage or injury. Sometimes other conditions may be associated with pyoderma gangrenosum, such as inflammatory bowel disease (IBD), arthritis or certain blood disorders. It is important to know that having pyoderma gangrenosum does not mean that you have these diseases.

What does pyoderma gangrenosum look like?

Pyoderma gangrenosum usually occurs in young and middle-aged adults but the way it looks can vary from person to person. It may start as a small pimple, red bump or blood-blister. The skin then breaks down resulting in an ulcer which often oozes fluid. The ulcer can enlarge rapidly. The edge of the ulcer may look purplish. The most common places where pyoderma gangrenosum occurs are the legs, although it can be found anywhere on the body. Sometimes it may occur around the site of a stoma (e.g. colostomy), or in a surgical wound.

What are the symptoms of pyoderma gangrenosum?

In pyoderma gangrenosum, there is usually a single large ulcer but occasionally there may be multiple ulcers. Ulcers may become infected, oozing fluid or pus. Pain or discomfort are common symptoms. Pyoderma gangrenosum is not cancer and does not lead to cancer.

How is pyoderma gangrenosum diagnosed?

There is no specific blood test for pyoderma gangrenosum. Certain conditions such as venous ulcers, inflammation of blood vessels, infection, injury, inflammatory disorders and cancer can look like pyoderma gangrenosum. This is why your doctor may take a sample of skin (biopsy) to examine under the microscope in a laboratory to confirm the diagnosis. The wound should also be swabbed and cultured for bacteria to rule out associated infection. Your doctor may also request blood tests to check for conditions that may be associated with pyoderma gangrenosum.

It is not hereditary and is not passed from parents to sons or daughters.

How can pyoderma gangrenosum be treated?

Pyoderma gangrenosum is treatable but may take some time to heal. More than one treatment may need to be tried; however skin grafts and surgery are not treatment options as this may result in enlargement of the ulcer. 

Treatment may be divided into local treatment (topical), systemic and biologics depending upon the severity of the disease.

1. Local applications to the skin (topical treatments)

Strong steroid ointments or creams often help, especially with small ulcers, and may help to reduce the pain.

2. Systemic treatments

  • Antibiotics (e.g. dapsone) are useful when treating small ulcers. Dapsone may affect the haemoglobin in the blood. Blood tests are performed weekly to begin with, and patients are asked to report any unusual symptoms (sore throat, dizziness or faintness) urgently to their doctor. Dapsone also causes some patients to have headaches.
  • Steroid tablets (e.g. prednisolone) are used to reduce inflammation.  They may be used alone or in combination with immunosuppressive agents. Prednisolone side effects include high blood pressure (hypertension) and high blood sugar (diabetes). Long-term use is associated with bone thinning (osteoporosis). If you have never had chickenpox, you should avoid close contact with people who have chickenpox or shingles.  If you do come into contact with chickenpox see your doctor urgently. You will need to carry a card if you take steroid tablets for a long time.
  • Immunosuppressive agents – these medicines reduce the action of the body’s own defence system (the immune system).  They are used mainly to make kidney, liver and heart transplants successful, but are also useful in treating severe pyoderma gangrenosum. Each one of these has certain side effects; monitoring for these are important aspects of your care. Immunosuppressive agents include:

- Mycophenolate mofetil – you will require regular blood tests, particularly to look at your liver and kidney function. 

- Ciclosporin - you will require regular blood pressure checks, urine and blood tests to look at kidney function.

- Azathioprine – requires regular blood tests. It is important to report any temperatures or sore throats urgently to your doctor.

If these medications are ineffective, your doctor could consider other potent immunosuppressive agents.

Where can I get more information about pyoderma gangrenosum?

Web links to detailed leaflets:

http://emedicine.medscape.com/article/1123821-overview
http://www.dermnetnz.org/reactions/pyoderma-gangrenosum.html

The British Skin Foundation fund vital research into all skin diseases.  To find out how you can help, please visit the British Skin Foundation website here.

This leaflet aims to provide accurate information about the subject and is a consensus of the views held by representatives of the British Association of Dermatologists: its contents, however, may occasionally differ from the advice given to you by your doctor.

This leaflet has been assessed for readability by the British Association of Dermatologists’ Patient Information Lay Review Panel

BRITISH ASSOCIATION OF DERMATOLOGISTS
PATIENT INFORMATION LEAFLET
PRODUCED JUNE 2010

 

 
 
web master
©2008 British Association of Dermatologists